» Articles » PMID: 22553621

Epidemiology and Rb1 Gene of Retinoblastoma

Overview
Specialty Ophthalmology
Date 2012 May 4
PMID 22553621
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoblastoma (Rb) is the most common eye cancer in children and it can be inherited. Rb is quite rare and originators from the neural retina with a significant genetic component in etiology, which occurs in approximately 1 in every 20 0000 births. In children with the heritable genetic form of Rb, there is a mutation on chromosome 13, called the retinoblastoma 1 (Rb1) gene. Early diagnosis and intervention is critical to the successful treatment of the Rb. The Rb1 gene is the first cloned tumor suppressor gene. As a negative regulator of the cell cycle, Rb1 gene could maintain a balance between cell growth and development through binding to transcription factors and regulating the expression of genes involved in cell proliferation and differentiation. Thus, it is involved in cell cycle, cell senescence, growth arrest, apoptosis and differentiation. We summarized the recent advances on the epidemiology and Rb1 gene of Rb in this review.

Citing Articles

Whole-Exome Analysis and Osteosarcoma: A Game Still Open.

Chiappetta C, Della Rocca C, Di Cristofano C Int J Mol Sci. 2025; 25(24.

PMID: 39769419 PMC: 11728052. DOI: 10.3390/ijms252413657.


Diagnostics and Therapy for Malignant Tumors.

Tsai C, Wang C, Chang H, Chang P, Chang C, Chu T Biomedicines. 2025; 12(12.

PMID: 39767566 PMC: 11726849. DOI: 10.3390/biomedicines12122659.


Expression of Wnt signaling proteins LEF1, β-catenin, GSK3β, DVL1, and N-myc varies across retinoblastoma subtypes and pRb phosphorylation status.

Markovic L, Bukovac A, Varosanec A, Jakovcevic A, Tomas D, Sonicki Z Sci Rep. 2024; 14(1):31725.

PMID: 39738380 PMC: 11685868. DOI: 10.1038/s41598-024-82044-z.


Global, regional and national burden due to retinoblastoma in children aged younger than 10 years from 1990 to 2021.

Li C, Zhang L, Zhang J, Jiao J, Hua G, Wang Y BMC Med. 2024; 22(1):604.

PMID: 39736662 PMC: 11686879. DOI: 10.1186/s12916-024-03827-9.


Prospects of anti-GD2 immunotherapy for retinoblastoma.

Zhang X, You W, Wang Y, Dejenie R, Wang C, Huang Y Front Immunol. 2024; 15:1499700.

PMID: 39620227 PMC: 11604707. DOI: 10.3389/fimmu.2024.1499700.


References
1.
MacCarthy A, Bayne A, Draper G, Eatock E, Kroll M, Stiller C . Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol. 2009; 93(9):1159-62. DOI: 10.1136/bjo.2008.146035. View

2.
Lim Z, Quah B . Unilateral retinoblastoma in an eye with Peters anomaly. J AAPOS. 2010; 14(2):184-6. DOI: 10.1016/j.jaapos.2010.02.005. View

3.
Vance K, Shaw H, Rodriguez M, Ott S, Goding C . The retinoblastoma protein modulates Tbx2 functional specificity. Mol Biol Cell. 2010; 21(15):2770-9. PMC: 2912361. DOI: 10.1091/mbc.E09-12-1029. View

4.
Gupta R, Vemuganti G, Reddy V, Honavar S . Histopathologic risk factors in retinoblastoma in India. Arch Pathol Lab Med. 2009; 133(8):1210-4. DOI: 10.5858/133.8.1210. View

5.
MacCarthy A, Bunch K, Fear N, King J, Vincent T, Murphy M . Paternal occupation and retinoblastoma: a case-control study based on data for Great Britain 1962-1999. Occup Environ Med. 2009; 66(10):644-9. DOI: 10.1136/oem.2007.037218. View